Clinical Trial Update: Clinical Study of Apatinib and 5-Fu Combination Regimen to Treat Advanced Colorectal Cancer Patients [Phase 2]

View source ↗

Summary

A phase 2 clinical trial update describes the combination of apatinib and 5-fluorouracil for metastatic colorectal cancer, with current status not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Apatinib (apatinib)

Snippet

Sponsor: Hui ting Xu，MD | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: UNKNOWN